CURE Trial
(Last Updated - 6/21/2007)

"Effects Of Clopidogrel In Addition To Aspirin In Patients With Acute Coronary Syndromes Without ST-Segment Elevation"
     NEJM: 8/16/2001 - Volume 345(7): Pages 494-502.

-Plavix 300 initial load then 75 QDay & Aspirin vs. Placebo & Aspirin

-Primary Outcomes:
     1) Death from CV cause
     2) Non-fatal MI
     3) CVA

-9.3% w/ Plavix vs. 11.4% w/ Placebo --> 2.1% difference (benefit)

-Secondary Outcome:
     -Refractory Ischemia

16.5% w/ Plavix vs. 18.8% w/ placebo --> 2.3% difference (benefit)

-Side Effex:
     -Major bleeding

-3.7% w/ Plavix vs. 2.7% w/ placebo --> 1.0% difference (risk)

==============================================
References: